1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
69DA8A39186D1E5EE00258ACF0039FC55
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/database-case-studies?OpenForm&Start=1&Count=10
18
19OpenForm&Start=1&Count=10
2044.220.62.183
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25




Case Studies

Displaying 1 - 10 of 62 Total Results.

DB Image

Case Study: How Horizon Therapeutics Created an Ophthalmic Blockbuster in a Rare Disease Autoimmune Area for Thyroid Eye DiseaseDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from “Case Study: How Horizon Therapeutics Created an Ophthalmic Blockbuster in a Rare Dise... (ID 5760)
Companies Profiled: Amgen, Horizon Therapeutics


DB Image

Case Study: How argenx Broke Into A Captive Market To Begin Dislodging An Entrenched Market LeaderDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from “Case Study: How argenx Broke Into A Captive Market To Begin Dislodging An Entrenched ... (ID 5757)
Companies Profiled: argenx, Alexion Pharmaceuticals, AstraZeneca


DB Image

Skyrizi Case Study: How Compressing Cycle Time from Launch to DTC Helps Support Sales Uptake of a Rising New Blockbuster ProductDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from “Skyrizi Case Study: How Compressing Cycle Time from Launch to DTC Helps Support Sales... (ID 5629)
Companies Profiled: AbbVie


DB Image

Skyrizi Case Study: Developing Early Comparative Effectiveness and Outcomes Studies to Lift Launch Uptake Curve & Accelerate Planned Obsolescence of AbbVie’s Own BlockbusterDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from “Skyrizi Case Study: Developing Early Comparative Effectiveness and Outcomes Studies t... (ID 5625)
Companies Profiled: AbbVie


DB Image

COVID-19 Challenges for Product Launch Timelines and Activities (including launch case studies on Nexletol, Trodelvy, Vumerity, and Zeposia)Direct access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from “COVID-19 Challenges for Product Launch Timelines and Activities (including case studi... (ID 5633)
Companies Profiled: AMAG Pharmaceuticals, Almirall, Alkermes, Amicus Therapeutics, more ...


DB Image

Growing Your Medical Device Business in Asia-Pacific & Latin America: Success Factors & Case Studies of Individual MarketsDirect access to this research is not included with your membership level.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from “Growing Your Medical Device Business in Asia-Pacific & Latin America: Success Factors... (ID 5504)
Companies Profiled: B.Braun, Boston Scientific, Cochlear, Fine Science Tools, more ...


DB Image

Tecfidera Case Study: Using Safety as a Springboard for Blockbuster StatusDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Tecfidera Case Study: Using Safety as a Springboard for Blockbuster Status" STUDY OVE... (ID 5360)
Companies Profiled: Biogen, Sanofi, Novartis


DB Image

Incivek Case Study: A Well Planned and Executed Launch Makes the Most of a Small Window of OpportunityDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Incivek Case Study: A Well Planned and Executed Launch Makes the Most of a Small Wind... (ID 5346)
Companies Profiled: Merck, Gilead Sciences, Vertex Pharmaceuticals


DB Image

Effexor Case Study: Using an Efficacy Message to Drive a Brand to the Top of a Crowded MarketDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Effexor Case Study: Using an Efficacy Message to Drive a Brand to the Top of a Crowde... (ID 5220)
Companies Profiled: Wyeth


DB Image

Diovan Case Study: Long-Term Brand Building in The Competitive Antihypertensive MarketDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Diovan Case Study: Long-Term Brand Building in the Competitive Antihypertensive Marke... (ID 5222)
Companies Profiled: Novartis